> News
 > TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany
News
29/11/2022

TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany

TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® Satylia® in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. […]

Access the press release

Our news

09/11/2023
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
> READ
Events
19/01/2023
Microbiota & Health Day 2023
> READ
News
23/01/2024
Focus SoHO et Paquet Pharma
> READ
> See all news